ScholarIQanswers from OpenAlex & ORCID
Maarten C.C.M. Hulshof
ResearcherPublications, citations & collaboration network
Maarten C.C.M. Hulshof is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Maarten C.C.M. Hulshof have?
ScholarIQindexed works
Maarten C.C.M. Hulshof has 399 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Maarten C.C.M. Hulshof have?
ScholarIQcitation count
Maarten C.C.M. Hulshof has 19,926 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Maarten C.C.M. Hulshof?
ScholarIQh-index
Maarten C.C.M. Hulshof has an h-index of 51 in OpenAlex.
What is the i10-index of Maarten C.C.M. Hulshof?
ScholarIQi10-index
Maarten C.C.M. Hulshof has an i10-index of 172 in OpenAlex.
What is the ORCID of Maarten C.C.M. Hulshof?
ScholarIQorcid
The ORCID for Maarten C.C.M. Hulshof is on the source record.
What is the OpenAlex record for Maarten C.C.M. Hulshof?
ScholarIQopenalex
The OpenAlex for Maarten C.C.M. Hulshof is on the source record.
What are the most-cited papers on Maarten C.C.M. Hulshof?
ScholarIQmost cited works
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot, Ewout W. Steyerberg, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Dick J. Richel, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, F.J.W. ten Kate, G.J. Creemers, C.J.A. Punt, John Theodorus Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, H.W. Tilanus, Ate van der Gaast
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, Pieter van Hagen, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Hanneke W.M. van Laarhoven, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, Fiebo J.W. ten Kate, Geert-Jan Creemers, Cornelis J.A. Punt, John Th. M. Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, Hugo W. Tilanus, Ewout W. Steyerberg, Ate van der Gaast
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
Ben M. Eyck, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, Berend J. van der Wilk, Joël Shapiro, Pieter van Hagen, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Hanneke W. M. van Laarhoven, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, Geert-Jan Creemers, Cornelis J.A. Punt, John Th. M. Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Maurice J.C. van der Sangen, Tom Rozema, Fiebo J.W. ten Kate, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, Hugo W. Tilanus, Ewout W. Steyerberg, Ate van der Gaast, for the CROSS Study Group